Whole genome analysis on the genetic backgrounds associated with the secondary failure to etanercept in patients with rheumatoid arthritis.

about

Whole genome analysis on the genetic backgrounds associated with the secondary failure to etanercept in patients with rheumatoid arthritis.

Item

http://www.wikidata.org/entity/Q51641849

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Whole genome analysis on the g ...... nts with rheumatoid arthritis.

@en

Whole genome analysis on the g ...... nts with rheumatoid arthritis.

@nl

type

Item

label

Whole genome analysis on the g ...... nts with rheumatoid arthritis.

@en

Whole genome analysis on the g ...... nts with rheumatoid arthritis.

@nl

prefLabel

Whole genome analysis on the g ...... nts with rheumatoid arthritis.

@en

Whole genome analysis on the g ...... nts with rheumatoid arthritis.

@nl

P1476

Whole genome analysis on the g ...... nts with rheumatoid arthritis.

@en

P2093

Hirotoshi Echizen

http://www.w3.org/2001/XMLSchema#string

Keiko Funahashi

http://www.w3.org/2001/XMLSchema#string

Satoru Koyano

http://www.w3.org/2001/XMLSchema#string

Tsukasa Matsubara

http://www.w3.org/2001/XMLSchema#string

P2860

Stk10, a new member of the polo-like kinase kinase family highly expressed in hematopoietic tissue

Opposing roles of serine/threonine kinases MEKK1 and LOK in regulating the CD28 responsive element in T-cells

PLINK: a tool set for whole-genome association and population-based linkage analyses

Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis

Genetics of rheumatoid arthritis contributes to biology and drug discovery

Identification of rheumatoid arthritis and osteoarthritis patients by transcriptome-based rule set generation.

Outcomes of switching anti-TNF drugs in rheumatoid arthritis--a study based on observational data from the Finnish Register of Biological Treatment (ROB-FIN).

Phase III, multicenter, open-label, long-term study of the safety of abatacept in Japanese patients with rheumatoid arthritis and an inadequate response to conventional or biologic disease-modifying antirheumatic drugs.

Adalimumab elicits a restricted anti-idiotypic antibody response in autoimmune patients resulting in functional neutralisation.

Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci.

P304

271-277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14397595.2016.1206172

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27416107

http://www.w3.org/2001/XMLSchema#string